ecg data Search Results


90
BIOPAC ecg and respiration data recording system
Ecg And Respiration Data Recording System, supplied by BIOPAC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecg and respiration data recording system/product/BIOPAC
Average 90 stars, based on 1 article reviews
ecg and respiration data recording system - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
POWERLAB INC analog waveforms of simultaneous ecg and multi channel scg data
Analog Waveforms Of Simultaneous Ecg And Multi Channel Scg Data, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/analog waveforms of simultaneous ecg and multi channel scg data/product/POWERLAB INC
Average 90 stars, based on 1 article reviews
analog waveforms of simultaneous ecg and multi channel scg data - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
AliveCor Inc ecg data
Ecg Data, supplied by AliveCor Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecg data/product/AliveCor Inc
Average 90 stars, based on 1 article reviews
ecg data - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
BIOPAC ecg data transmission system
Ecg Data Transmission System, supplied by BIOPAC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecg data transmission system/product/BIOPAC
Average 90 stars, based on 1 article reviews
ecg data transmission system - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
BIOPAC electrocardiogram data
Electrocardiogram Data, supplied by BIOPAC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/electrocardiogram data/product/BIOPAC
Average 90 stars, based on 1 article reviews
electrocardiogram data - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
TenCent Inc ecg data
Ecg Data, supplied by TenCent Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecg data/product/TenCent Inc
Average 90 stars, based on 1 article reviews
ecg data - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Celerion Inc ecg data
Study design (Part B). a There was a washout of ≥ 21 days between dosing in each period. b Screening of study participants occurred within 28 days prior to first dosing. c All participants who received ≥ 1 dose of study drug (including participants who terminated the study early) returned to the CRU 30 (± 2) days after the last dose for follow‐up procedures and to determine if any AE occurred since the last study visit. AE, adverse event; CRU, clinical research unit; <t>ECG,</t> <t>electrocardiogram;</t> n , sample size; PK, pharmacokinetics.
Ecg Data, supplied by Celerion Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecg data/product/Celerion Inc
Average 90 stars, based on 1 article reviews
ecg data - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Cambridge Heart Inc digital 12-lead ecg data
Study design (Part B). a There was a washout of ≥ 21 days between dosing in each period. b Screening of study participants occurred within 28 days prior to first dosing. c All participants who received ≥ 1 dose of study drug (including participants who terminated the study early) returned to the CRU 30 (± 2) days after the last dose for follow‐up procedures and to determine if any AE occurred since the last study visit. AE, adverse event; CRU, clinical research unit; <t>ECG,</t> <t>electrocardiogram;</t> n , sample size; PK, pharmacokinetics.
Digital 12 Lead Ecg Data, supplied by Cambridge Heart Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/digital 12-lead ecg data/product/Cambridge Heart Inc
Average 90 stars, based on 1 article reviews
digital 12-lead ecg data - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Rozinn Electronics Inc holter ecg data rozinn electronics h4w 3.6f
Study design (Part B). a There was a washout of ≥ 21 days between dosing in each period. b Screening of study participants occurred within 28 days prior to first dosing. c All participants who received ≥ 1 dose of study drug (including participants who terminated the study early) returned to the CRU 30 (± 2) days after the last dose for follow‐up procedures and to determine if any AE occurred since the last study visit. AE, adverse event; CRU, clinical research unit; <t>ECG,</t> <t>electrocardiogram;</t> n , sample size; PK, pharmacokinetics.
Holter Ecg Data Rozinn Electronics H4w 3.6f, supplied by Rozinn Electronics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/holter ecg data rozinn electronics h4w 3.6f/product/Rozinn Electronics Inc
Average 90 stars, based on 1 article reviews
holter ecg data rozinn electronics h4w 3.6f - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
BioSemi ecg and gsr data
Study design (Part B). a There was a washout of ≥ 21 days between dosing in each period. b Screening of study participants occurred within 28 days prior to first dosing. c All participants who received ≥ 1 dose of study drug (including participants who terminated the study early) returned to the CRU 30 (± 2) days after the last dose for follow‐up procedures and to determine if any AE occurred since the last study visit. AE, adverse event; CRU, clinical research unit; <t>ECG,</t> <t>electrocardiogram;</t> n , sample size; PK, pharmacokinetics.
Ecg And Gsr Data, supplied by BioSemi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecg and gsr data/product/BioSemi
Average 90 stars, based on 1 article reviews
ecg and gsr data - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Biotrial Inc ecg data
Study design (Part B). a There was a washout of ≥ 21 days between dosing in each period. b Screening of study participants occurred within 28 days prior to first dosing. c All participants who received ≥ 1 dose of study drug (including participants who terminated the study early) returned to the CRU 30 (± 2) days after the last dose for follow‐up procedures and to determine if any AE occurred since the last study visit. AE, adverse event; CRU, clinical research unit; <t>ECG,</t> <t>electrocardiogram;</t> n , sample size; PK, pharmacokinetics.
Ecg Data, supplied by Biotrial Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecg data/product/Biotrial Inc
Average 90 stars, based on 1 article reviews
ecg data - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
SAS institute single-lead electrocardiogram (ecg) data
Study design (Part B). a There was a washout of ≥ 21 days between dosing in each period. b Screening of study participants occurred within 28 days prior to first dosing. c All participants who received ≥ 1 dose of study drug (including participants who terminated the study early) returned to the CRU 30 (± 2) days after the last dose for follow‐up procedures and to determine if any AE occurred since the last study visit. AE, adverse event; CRU, clinical research unit; <t>ECG,</t> <t>electrocardiogram;</t> n , sample size; PK, pharmacokinetics.
Single Lead Electrocardiogram (Ecg) Data, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/single-lead electrocardiogram (ecg) data/product/SAS institute
Average 90 stars, based on 1 article reviews
single-lead electrocardiogram (ecg) data - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Study design (Part B). a There was a washout of ≥ 21 days between dosing in each period. b Screening of study participants occurred within 28 days prior to first dosing. c All participants who received ≥ 1 dose of study drug (including participants who terminated the study early) returned to the CRU 30 (± 2) days after the last dose for follow‐up procedures and to determine if any AE occurred since the last study visit. AE, adverse event; CRU, clinical research unit; ECG, electrocardiogram; n , sample size; PK, pharmacokinetics.

Journal: Clinical and Translational Science

Article Title: Clinical Evaluation of the Effect of Aficamten on QT / QTc Interval in Healthy Participants

doi: 10.1111/cts.70218

Figure Lengend Snippet: Study design (Part B). a There was a washout of ≥ 21 days between dosing in each period. b Screening of study participants occurred within 28 days prior to first dosing. c All participants who received ≥ 1 dose of study drug (including participants who terminated the study early) returned to the CRU 30 (± 2) days after the last dose for follow‐up procedures and to determine if any AE occurred since the last study visit. AE, adverse event; CRU, clinical research unit; ECG, electrocardiogram; n , sample size; PK, pharmacokinetics.

Article Snippet: ECG data were measured by Celerion ECG core laboratory by employing one board‐certified cardiologist and read in a blinded manner.

Techniques: Drug discovery

Cardiodynamic categorical summary by treatment in Part B <xref ref-type= a , b ." width="100%" height="100%">

Journal: Clinical and Translational Science

Article Title: Clinical Evaluation of the Effect of Aficamten on QT / QTc Interval in Healthy Participants

doi: 10.1111/cts.70218

Figure Lengend Snippet: Cardiodynamic categorical summary by treatment in Part B a , b .

Article Snippet: ECG data were measured by Celerion ECG core laboratory by employing one board‐certified cardiologist and read in a blinded manner.

Techniques: